Project Grant R01AI174584
- This federal Project Grant award of $146,922 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the factors that modulate the efficiency of influenza A virus (IAV) infection in a recipient host. The research team from Emory University will conduct intranasal and aerosol inoculations in guinea pigs to model direct and airborne transmission, using barcoded libraries of...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,074,701 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Emory University. The project, titled "Drivers of Influenza A Virus Transmission in Humans," aims to address gaps in understanding the biological and physical processes underlying the transmission of influenza A virus in humans. The key objectives are to: 1) Define the dynamics of viral load, immunological...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to investigate the role of phosphoinositides in influenza virus assembly. The $430,613 award to the University of Maine System will fund a 3-year project to study how the viral surface glycoprotein hemagglutinin and the matrix protein M1 interact with host cell phosphoinositides to facilitate virus cluster formation and...
- Federal Grant Award Summary Emory University received a $346,214 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on June 27, 2025, with a completion date of January 31, 2028. The grant supports investigator-initiated biomedical research focused on identifying and characterizing the mechanisms underlying beneficial effects of influenza A virus (IAV) co-infection within host...
- This Project Grant award of $392,500.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports a research program at Arizona State University (ASU) focused on improving the understanding of cross-species viral transmission from wild mammals to humans. The key objectives of the five-year project are to: 1) develop automated tools to curate and maintain up-to-date taxonomic data on mammal and virus species, 2) test...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $661,313 Project Grant (R01) to Massachusetts General Hospital effective February 6, 2026, through January 31, 2031, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research focuses on developing a universal influenza vaccine by eliciting pan-influenza A broadly neutralizing antibodies (BNAbs) through engineered nanoparticle immunogens. The investigation...
- Summary Louisiana State University will develop novel mucosal vaccines to protect poultry from Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.3.4.4b under a $1.92 million Cooperative Agreement awarded by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025). The project, which commenced February 2, 2026, and concludes February 1, 2029, will deliver three primary...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Washington a Project Grant of $414,305 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct investigator-initiated biomedical research on influenza neuraminidase structure and dynamics. The award, obligated on February 19, 2026, with completion targeted for January 31, 2028, funds research examining how structural variation in the neuraminidase...
- This $649,999 federal Project Grant award was provided by the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) through the Agriculture and Food Research Initiative (AFRI) program. The purpose is to evaluate the risk of H5N1 influenza virus spillover from cattle to swine. The primary awardee, The Ohio State University, will lead animal studies to assess virus transmission and viral replication in cattle and swine, including intranasal and intramammary inoculation...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $438,500 Project Grant to the University of California, San Diego under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 8, 2025, with a completion date of June 30, 2027. This award funds investigator-initiated biomedical research examining the sequence-specific determinants and impacts of NS2 (nonstructural protein 2) interactions with the Influenza A Virus...
INVESTIGATION OF HOST GLYCAN REQUIREMENTS FOR THE TRANSMISSION OF INFLUENZA VIRUSES AT THE HUMAN-ANIMAL INTERFACE - ABSTRACT INFLUENZA A VIRUSES (IAV) POSE A CONSTANT THREAT TO HUMAN HEALTH THROUGH BOTH SEASONAL EPIDEMICS AND OCCASIONAL PANDEMICS, WHICH ARE OFTEN CAUSED BY TRANSMISSION OF IAV STRAINS FROM ZOONOTIC RESERVOIRS. WITH THE EXCEPTION OF BAT IAV, ALL OTHER IAV STRAINS INFECT HOST CELLS BY BINDING TO SIALIC ACID ON GLYCOCONJUGATES (SIALOGLYCANS). VARIOUS TYPES OF CELL SURFACE SIALOGLYCANS (N-GLYCANS, O-GLYCANS, GLYCOLIPIDS) DISPLAY SIGNIFICANT DIVERSITY IN BOTH STRUCTURE AND CARBOHYDRATE COMPOSITION. IN ADDITION, THE SIALOGLYCAN REPERTOIRE CAN VARY BETWEEN CELL TYPES AND ACROSS DIFFERENT IAV HOST SPECIES. THUS, DEFINING THE STRUCTURAL FEATURES IN SIALOGLYCANS NECESSARY FOR IAV INFECTION ACROSS DIFFERENT HOST SPECIES IS CRITICAL FOR OUR UNDERSTANDING OF ZOONOTIC TRANSMISSION INTO HUMANS. IMPORTANTLY, THERE ARE NO RELIABLE STRATEGIES THAT CAN COMPREHENSIVELY ASSESS AND IDENTIFY ZOONOTIC IAV STRAINS CAPABLE OF CAUSING HUMAN INFECTIONS. TO DEFINE THE TYPES OF SIALOGLYCANS THAT FACILITATE IAV INFECTION, WE UTILIZED THE CRISPR/CAS9 TECHNIQUE AND TRUNCATED DIFFERENT TYPES OF SIALOGLYCANS IN A HUMAN LUNG EPITHELIAL CELL LINE EITHER INDIVIDUALLY OR IN COMBINATION, BY TARGETING GLYCOSYLTRANSFERASES ESSENTIAL TO BIOSYNTHESIS. OUR STUDIES SHOW THAT SIALIC ACID ON N-GLYCANS, O-GLYCANS AND GLYCOLIPIDS CAN INDEPENDENTLY SERVE AS A RECEPTOR FOR SEVERAL IAV STRAINS FROM BOTH HUMAN AND ZOONOTIC HOSTS. INTERESTINGLY, TRUNCATION OF ALL THREE TYPES OF GLYCANS SIGNIFICANTLY DECREASED THE REPLICATION OF HUMAN BY NOT AVIAN IAV STRAINS, DEMONSTRATING THAT IAV STRAINS FROM AVIAN HOSTS ARE MORE FLEXIBLE IN THEIR REQUIREMENT OF SIALOGLYCAN STRUCTURES. HERE WE PROPOSE TO UTILIZE THE CRISPR/CAS9 TECHNIQUE TO DEFINE THE STRUCTURAL FEATURES OF SAILOGLYCANS NECESSARY FOR IAV INFECTION AND ADAPTATION ACROSS VARIOUS HOST SPECIES USING PRIMARY DIFFERENTIATED CELLS. IMPORTANTLY, WE WILL DEVELOP A SINGLE CELL MULTI-OMICS PLATFORM TO RELIABLY IDENTIFY ZOONOTIC IAV STRAINS WITH THE POTENTIAL TO CAUSE HUMAN INFECTIONS. THESE STUDIES WILL PROVIDE SIGNIFICANT INSIGHTS INTO OUR UNDERSTANDING OF HOW THE SIALOGLYCAN REPERTOIRE SHAPES HOST ADAPTATION AND FITNESS OF IAV STRAINS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $749.2k | 8/15/25 | ||
| Not listed | $792.7k | 7/26/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
S0514201S | University Of Maryland, College Park | Project Grant R01AI174584 | $57.1k | 11/26/25 | |
S0514301S | University Of Illinois | Project Grant R01AI174584 | $44.7k | 10/23/25 | |
S0514401S | The Research Foundation For The State University Of New York | Project Grant R01AI174584 | $120.8k | 10/23/25 | |
S0514401S | The Research Foundation For The State University Of New York | Project Grant R01AI174584 | $120.8k | 12/18/24 | |
S0514201S | University Of Maryland, College Park | Project Grant R01AI174584 | $76.1k | 12/18/24 |